Sio Capital Management, LLC Intra Cellular Therapies, Inc. Transaction History
Sio Capital Management, LLC
- $289 Million
- Q3 2025
A detailed history of Sio Capital Management, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Sio Capital Management, LLC holds 1,946,800 shares of ITCI stock, worth $257 Million. This represents 15.91% of its overall portfolio holdings.
Number of Shares
1,946,800Holding current value
$257 Million% of portfolio
15.91%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ITCI
# of Institutions
33Shares Held
10.6MCall Options Held
600Put Options Held
0-
Black Rock Inc. New York, NY6.32MShares$834 Million0.01% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.67MShares$220 Million0.13% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL625KShares$82.4 Million0.27% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL519KShares$68.5 Million0.01% of portfolio
-
Cibra Capital LTD London, X0416KShares$54.9 Million18.76% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...